Kayne Anderson Rudnick Investment Management LLC Bluebird Bio, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $215 - $440	-13 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $357 - $492	13 New	13 $1,000
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $601 - $1,460	-23 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$46.96 - $61.67 $5.81 Million - $7.63 Million	-123,721 Reduced 99.98%	23 $2,000
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $1.72 Million - $2.69 Million	28,927 Added 30.51%	123,744 $11.4 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $315,494 - $437,673	4,160 Added 4.59%	94,817 $12.1 Million
Q1 2019 Jun 12, 2019	SELL	$64.44 - $104.11 $2,126 - $3,435	-33 Reduced 0.04%	90,657 $14.3 Million
Q1 2019 May 10, 2019	BUY	$64.44 - $104.11 $853,250 - $1.38 Million	13,241 Added 17.1%	90,690 $14.3 Million
Q4 2018 Feb 06, 2019	SELL	$59.1 - $93.26 $671,198 - $1.06 Million	-11,357 Reduced 12.79%	77,449 $7.68 Million
Q3 2018 Nov 13, 2018	BUY	$88.86 - $117.49 $56,781 - $75,076	639 Added 0.72%	88,806 $13 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $349,238 - $447,202	3,505 Added 4.14%	88,167 $13.8 Million
Q1 2018 May 09, 2018	BUY	$105.8 - $150.94 $8.96 Million - $12.8 Million	84,662 New	84,662 $14.5 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account